0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metabotropic Glutamate Receptor 5 Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-27O290
Home | Market Reports | Science | Biological Sciences | Neuroscience
Global Metabotropic Glutamate Receptor 5 Market Insights and Forecast to 2028

Global Metabotropic Glutamate Receptor 5 Market Insights and Forecast to 2028

Code: QYRE-Auto-27O290
Report
January 2022
106 Pages
QYResearch
Region: Global, Japan, Europe, India, North America, Southeast Asia,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Metabotropic Glutamate Receptor 5 Market

Due to the COVID-19 pandemic, the global Metabotropic Glutamate Receptor 5 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Alloswitch-1 accounting for % of the Metabotropic Glutamate Receptor 5 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Major Depressive Disorder segment is altered to an % CAGR throughout this forecast period.
China Metabotropic Glutamate Receptor 5 market size is valued at US$ million in 2021, while the US and Europe Metabotropic Glutamate Receptor 5 are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Metabotropic Glutamate Receptor 5 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Metabotropic Glutamate Receptor 5 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Eisai Co Ltd, Eli Lilly and Company, Heptares Therapeutics Ltd, Johnson & Johnson, Merz Pharma GmbH & Co KgaA and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Metabotropic Glutamate Receptor 5 Scope and Segment
Metabotropic Glutamate Receptor 5 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 5 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others

Segment by Application

Major Depressive Disorder
Alcohol Addiction
Alzheimer's Disease
Others

BY COMPANY

Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Metabotropic Glutamate Receptor 5 Product Introduction
1.2 Market by Type
1.2.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Alloswitch-1
1.2.3 BMS-952048
1.2.4 BMS-955829
1.2.5 Dipraglurant ER
1.2.6 Others
1.3 Market by Application
1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Alcohol Addiction
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 5 Sales Estimates and Forecasts 2017-2028
2.2 Global Metabotropic Glutamate Receptor 5 Revenue Estimates and Forecasts 2017-2028
2.3 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Metabotropic Glutamate Receptor 5 Sales by Region
2.4.1 Global Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022)
2.4.2 Global Sales Metabotropic Glutamate Receptor 5 by Region (2023-2028)
2.5 Global Metabotropic Glutamate Receptor 5 Revenue by Region
2.5.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers
3.1.1 Global Top Metabotropic Glutamate Receptor 5 Manufacturers by Sales (2017-2022)
3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metabotropic Glutamate Receptor 5 in 2021
3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers
3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2017-2022)
3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 5 Revenue in 2021
3.3 Global Metabotropic Glutamate Receptor 5 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Metabotropic Glutamate Receptor 5 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metabotropic Glutamate Receptor 5 Sales by Type
4.1.1 Global Metabotropic Glutamate Receptor 5 Historical Sales by Type (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 5 Forecasted Sales by Type (2023-2028)
4.1.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
4.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type
4.2.1 Global Metabotropic Glutamate Receptor 5 Historical Revenue by Type (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 5 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
4.3 Global Metabotropic Glutamate Receptor 5 Price by Type
4.3.1 Global Metabotropic Glutamate Receptor 5 Price by Type (2017-2022)
4.3.2 Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 5 Sales by Application
5.1.1 Global Metabotropic Glutamate Receptor 5 Historical Sales by Application (2017-2022)
5.1.2 Global Metabotropic Glutamate Receptor 5 Forecasted Sales by Application (2023-2028)
5.1.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
5.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application
5.2.1 Global Metabotropic Glutamate Receptor 5 Historical Revenue by Application (2017-2022)
5.2.2 Global Metabotropic Glutamate Receptor 5 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
5.3 Global Metabotropic Glutamate Receptor 5 Price by Application
5.3.1 Global Metabotropic Glutamate Receptor 5 Price by Application (2017-2022)
5.3.2 Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Metabotropic Glutamate Receptor 5 Market Size by Type
6.1.1 North America Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
6.1.2 North America Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
6.2 North America Metabotropic Glutamate Receptor 5 Market Size by Application
6.2.1 North America Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
6.2.2 North America Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
6.3 North America Metabotropic Glutamate Receptor 5 Market Size by Country
6.3.1 North America Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
6.3.2 North America Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 5 Market Size by Type
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
7.2 Europe Metabotropic Glutamate Receptor 5 Market Size by Application
7.2.1 Europe Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
7.2.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
7.3 Europe Metabotropic Glutamate Receptor 5 Market Size by Country
7.3.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
7.3.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Type
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
8.2 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Application
8.2.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
8.2.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
8.3 Asia Pacific Metabotropic Glutamate Receptor 5 Market Size by Region
8.3.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2017-2028)
8.3.2 Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 5 Market Size by Type
9.1.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
9.1.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
9.2 Latin America Metabotropic Glutamate Receptor 5 Market Size by Application
9.2.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
9.2.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
9.3 Latin America Metabotropic Glutamate Receptor 5 Market Size by Country
9.3.1 Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
9.3.2 Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Type
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2028)
10.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Application
10.2.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2028)
10.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country
10.3.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Overview
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Addex Therapeutics Ltd Recent Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Corporation Information
11.2.2 Aevi Genomic Medicine Inc Overview
11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aevi Genomic Medicine Inc Recent Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Overview
11.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Company Recent Developments
11.4 Eisai Co Ltd
11.4.1 Eisai Co Ltd Corporation Information
11.4.2 Eisai Co Ltd Overview
11.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eisai Co Ltd Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Heptares Therapeutics Ltd
11.6.1 Heptares Therapeutics Ltd Corporation Information
11.6.2 Heptares Therapeutics Ltd Overview
11.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heptares Therapeutics Ltd Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Merz Pharma GmbH & Co KgaA
11.8.1 Merz Pharma GmbH & Co KgaA Corporation Information
11.8.2 Merz Pharma GmbH & Co KgaA Overview
11.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merz Pharma GmbH & Co KgaA Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Overview
11.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis AG Recent Developments
11.10 Richter Gedeon Nyrt
11.10.1 Richter Gedeon Nyrt Corporation Information
11.10.2 Richter Gedeon Nyrt Overview
11.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Richter Gedeon Nyrt Recent Developments
11.11 Sumitomo Dainippon Pharma Co Ltd
11.11.1 Sumitomo Dainippon Pharma Co Ltd Corporation Information
11.11.2 Sumitomo Dainippon Pharma Co Ltd Overview
11.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
11.12 Toray Industries Inc
11.12.1 Toray Industries Inc Corporation Information
11.12.2 Toray Industries Inc Overview
11.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Toray Industries Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Metabotropic Glutamate Receptor 5 Industry Chain Analysis
12.2 Metabotropic Glutamate Receptor 5 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metabotropic Glutamate Receptor 5 Production Mode & Process
12.4 Metabotropic Glutamate Receptor 5 Sales and Marketing
12.4.1 Metabotropic Glutamate Receptor 5 Sales Channels
12.4.2 Metabotropic Glutamate Receptor 5 Distributors
12.5 Metabotropic Glutamate Receptor 5 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Metabotropic Glutamate Receptor 5 Industry Trends
13.2 Metabotropic Glutamate Receptor 5 Market Drivers
13.3 Metabotropic Glutamate Receptor 5 Market Challenges
13.4 Metabotropic Glutamate Receptor 5 Market Restraints
14 Key Findings in The Global Metabotropic Glutamate Receptor 5 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Alloswitch-1
    Table 3. Major Manufacturers of BMS-952048
    Table 4. Major Manufacturers of BMS-955829
    Table 5. Major Manufacturers of Dipraglurant ER
    Table 6. Major Manufacturers of Others
    Table 7. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)
    Table 11. Global Metabotropic Glutamate Receptor 5 Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2023-2028)
    Table 13. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2017-2022)
    Table 15. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2023-2028)
    Table 17. Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global Metabotropic Glutamate Receptor 5 Sales Share by Manufacturers (2017-2022)
    Table 19. Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2017-2022)
    Table 21. Metabotropic Glutamate Receptor 5 Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global Metabotropic Glutamate Receptor 5 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Metabotropic Glutamate Receptor 5 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2021)
    Table 24. Metabotropic Glutamate Receptor 5 Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Metabotropic Glutamate Receptor 5 Product Offered
    Table 26. Date of Manufacturers Enter into Metabotropic Glutamate Receptor 5 Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global Metabotropic Glutamate Receptor 5 Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global Metabotropic Glutamate Receptor 5 Sales Share by Type (2017-2022)
    Table 31. Global Metabotropic Glutamate Receptor 5 Sales Share by Type (2023-2028)
    Table 32. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2017-2022)
    Table 35. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2023-2028)
    Table 36. Metabotropic Glutamate Receptor 5 Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global Metabotropic Glutamate Receptor 5 Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global Metabotropic Glutamate Receptor 5 Sales Share by Application (2017-2022)
    Table 41. Global Metabotropic Glutamate Receptor 5 Sales Share by Application (2023-2028)
    Table 42. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Metabotropic Glutamate Receptor 5 Revenue Share by Application (2017-2022)
    Table 45. Global Metabotropic Glutamate Receptor 5 Revenue Share by Application (2023-2028)
    Table 46. Metabotropic Glutamate Receptor 5 Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America Metabotropic Glutamate Receptor 5 Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Metabotropic Glutamate Receptor 5 Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America Metabotropic Glutamate Receptor 5 Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Metabotropic Glutamate Receptor 5 Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America Metabotropic Glutamate Receptor 5 Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Addex Therapeutics Ltd Corporation Information
    Table 109. Addex Therapeutics Ltd Description and Major Businesses
    Table 110. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Addex Therapeutics Ltd Recent Developments
    Table 113. Aevi Genomic Medicine Inc Corporation Information
    Table 114. Aevi Genomic Medicine Inc Description and Major Businesses
    Table 115. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Aevi Genomic Medicine Inc Recent Developments
    Table 118. Bristol-Myers Squibb Company Corporation Information
    Table 119. Bristol-Myers Squibb Company Description and Major Businesses
    Table 120. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Bristol-Myers Squibb Company Recent Developments
    Table 123. Eisai Co Ltd Corporation Information
    Table 124. Eisai Co Ltd Description and Major Businesses
    Table 125. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Eisai Co Ltd Recent Developments
    Table 128. Eli Lilly and Company Corporation Information
    Table 129. Eli Lilly and Company Description and Major Businesses
    Table 130. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Eli Lilly and Company Recent Developments
    Table 133. Heptares Therapeutics Ltd Corporation Information
    Table 134. Heptares Therapeutics Ltd Description and Major Businesses
    Table 135. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 136. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Heptares Therapeutics Ltd Recent Developments
    Table 138. Johnson & Johnson Corporation Information
    Table 139. Johnson & Johnson Description and Major Businesses
    Table 140. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 141. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Johnson & Johnson Recent Developments
    Table 143. Merz Pharma GmbH & Co KgaA Corporation Information
    Table 144. Merz Pharma GmbH & Co KgaA Description and Major Businesses
    Table 145. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 146. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Merz Pharma GmbH & Co KgaA Recent Developments
    Table 148. Novartis AG Corporation Information
    Table 149. Novartis AG Description and Major Businesses
    Table 150. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 151. Novartis AG Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Novartis AG Recent Developments
    Table 153. Richter Gedeon Nyrt Corporation Information
    Table 154. Richter Gedeon Nyrt Description and Major Businesses
    Table 155. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 156. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Richter Gedeon Nyrt Recent Developments
    Table 158. Sumitomo Dainippon Pharma Co Ltd Corporation Information
    Table 159. Sumitomo Dainippon Pharma Co Ltd Description and Major Businesses
    Table 160. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 161. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Sumitomo Dainippon Pharma Co Ltd Recent Developments
    Table 163. Toray Industries Inc Corporation Information
    Table 164. Toray Industries Inc Description and Major Businesses
    Table 165. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 166. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Toray Industries Inc Recent Developments
    Table 168. Key Raw Materials Lists
    Table 169. Raw Materials Key Suppliers Lists
    Table 170. Metabotropic Glutamate Receptor 5 Distributors List
    Table 171. Metabotropic Glutamate Receptor 5 Customers List
    Table 172. Metabotropic Glutamate Receptor 5 Market Trends
    Table 173. Metabotropic Glutamate Receptor 5 Market Drivers
    Table 174. Metabotropic Glutamate Receptor 5 Market Challenges
    Table 175. Metabotropic Glutamate Receptor 5 Market Restraints
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metabotropic Glutamate Receptor 5 Product Picture
    Figure 3. Global Metabotropic Glutamate Receptor 5 Market Share by Type in 2021 & 2028
    Figure 3. Alloswitch-1 Product Picture
    Figure 4. BMS-952048 Product Picture
    Figure 5. BMS-955829 Product Picture
    Figure 6. Dipraglurant ER Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Metabotropic Glutamate Receptor 5 Market Share by Application in 2021 & 2028
    Figure 9. Major Depressive Disorder
    Figure 10. Alcohol Addiction
    Figure 11. Alzheimer's Disease
    Figure 12. Others
    Figure 13. Metabotropic Glutamate Receptor 5 Report Years Considered
    Figure 14. Global Metabotropic Glutamate Receptor 5 Sales 2017-2028 (K Pcs)
    Figure 15. Global Metabotropic Glutamate Receptor 5 Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Metabotropic Glutamate Receptor 5 Revenue 2017-2028 (US$ Million)
    Figure 17. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)
    Figure 19. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2023-2028)
    Figure 20. North America Metabotropic Glutamate Receptor 5 Sales YoY (2017-2028) & (K Pcs)
    Figure 21. North America Metabotropic Glutamate Receptor 5 Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Metabotropic Glutamate Receptor 5 Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Europe Metabotropic Glutamate Receptor 5 Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Metabotropic Glutamate Receptor 5 Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Latin America Metabotropic Glutamate Receptor 5 Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales YoY (2017-2028) & (K Pcs)
    Figure 29. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Metabotropic Glutamate Receptor 5 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Metabotropic Glutamate Receptor 5 in the World: Market Share by Metabotropic Glutamate Receptor 5 Revenue in 2021
    Figure 32. Global Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
    Figure 34. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
    Figure 35. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
    Figure 36. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
    Figure 37. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
    Figure 38. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
    Figure 39. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
    Figure 40. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
    Figure 41. North America Metabotropic Glutamate Receptor 5 Sales Share by Country (2017-2028)
    Figure 42. North America Metabotropic Glutamate Receptor 5 Revenue Share by Country (2017-2028)
    Figure 43. U.S. Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
    Figure 46. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
    Figure 48. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Metabotropic Glutamate Receptor 5 Sales Share by Country (2017-2028)
    Figure 50. Europe Metabotropic Glutamate Receptor 5 Revenue Share by Country (2017-2028)
    Figure 51. Germany Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 52. France Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Metabotropic Glutamate Receptor 5 Revenue Share by Region (2017-2028)
    Figure 62. China Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 65. India Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Metabotropic Glutamate Receptor 5 Sales Share by Country (2017-2028)
    Figure 77. Latin America Metabotropic Glutamate Receptor 5 Revenue Share by Country (2017-2028)
    Figure 78. Mexico Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Share by Country (2017-2028)
    Figure 87. Turkey Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Metabotropic Glutamate Receptor 5 Revenue (2017-2028) & (US$ Million)
    Figure 90. Metabotropic Glutamate Receptor 5 Value Chain
    Figure 91. Metabotropic Glutamate Receptor 5 Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Deep Brain Stimulation System Market Insights and Forecast to 2026
Global Deep Brain Stimulation System Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-20Y3138
Fri Sep 09 00:00:00 UTC 2022

Add to Cart

Global 5 Hydroxytryptamine Receptor Blocker Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global 5 Hydroxytryptamine Receptor Blocker Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-29S11781
Fri Sep 09 00:00:00 UTC 2022

Add to Cart

Global Bicuculline Methiodide Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global (-)-Bicuculline Methiodide Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-9H12258
Thu Sep 08 00:00:00 UTC 2022

Add to Cart

Global Self Learning Neuromorphic Chip Market Research Report 2022
Global Self-Learning Neuromorphic Chip Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29P11083
Tue Jul 12 00:00:00 UTC 2022

Add to Cart